JP2014532728A5 - - Google Patents

Download PDF

Info

Publication number
JP2014532728A5
JP2014532728A5 JP2014540197A JP2014540197A JP2014532728A5 JP 2014532728 A5 JP2014532728 A5 JP 2014532728A5 JP 2014540197 A JP2014540197 A JP 2014540197A JP 2014540197 A JP2014540197 A JP 2014540197A JP 2014532728 A5 JP2014532728 A5 JP 2014532728A5
Authority
JP
Japan
Prior art keywords
composition according
hydrogen
group
composition
opioid agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014540197A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532728A (ja
JP6593993B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/063725 external-priority patent/WO2013070617A1/en
Publication of JP2014532728A publication Critical patent/JP2014532728A/ja
Publication of JP2014532728A5 publication Critical patent/JP2014532728A5/ja
Application granted granted Critical
Publication of JP6593993B2 publication Critical patent/JP6593993B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014540197A 2011-11-07 2012-11-06 オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与 Expired - Fee Related JP6593993B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161556693P 2011-11-07 2011-11-07
US61/556,693 2011-11-07
PCT/US2012/063725 WO2013070617A1 (en) 2011-11-07 2012-11-06 Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018118989A Division JP2018158940A (ja) 2011-11-07 2018-06-22 オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与

Publications (3)

Publication Number Publication Date
JP2014532728A JP2014532728A (ja) 2014-12-08
JP2014532728A5 true JP2014532728A5 (enExample) 2015-12-10
JP6593993B2 JP6593993B2 (ja) 2019-10-23

Family

ID=47297432

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014540197A Expired - Fee Related JP6593993B2 (ja) 2011-11-07 2012-11-06 オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与
JP2018118989A Withdrawn JP2018158940A (ja) 2011-11-07 2018-06-22 オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018118989A Withdrawn JP2018158940A (ja) 2011-11-07 2018-06-22 オピオイドアゴニスト化合物と鎮痛性化合物との組成物、剤形、および同時投与

Country Status (9)

Country Link
US (2) US9457024B2 (enExample)
EP (1) EP2776046A1 (enExample)
JP (2) JP6593993B2 (enExample)
KR (1) KR102016305B1 (enExample)
CN (1) CN103906522B (enExample)
AU (1) AU2012336030B2 (enExample)
CA (1) CA2854512A1 (enExample)
MX (1) MX348933B (enExample)
WO (1) WO2013070617A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10512644B2 (en) * 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US10525054B2 (en) * 2011-11-07 2020-01-07 Inheris Biopharma, Inc. Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
WO2013070617A1 (en) * 2011-11-07 2013-05-16 Nektar Therapeutics Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9688638B2 (en) 2013-11-27 2017-06-27 Nektar Therapeutics Opioid agonists and uses thereof
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN105111136B (zh) * 2015-09-16 2017-07-04 上海皓伯化工科技有限公司 一种制备3‑甲基‑1‑苯乙基哌啶‑4‑酮或1‑苯乙基哌啶‑4‑酮的方法
CN107033154B (zh) 2016-02-02 2020-02-04 上海瀚迈生物医药科技有限公司 阿片受体拮抗剂缀合物及其应用
CN117003693B (zh) * 2022-05-05 2026-01-30 四川大学华西医院 一类哌啶衍生物及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2654756A (en) 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
US2806033A (en) 1955-08-03 1957-09-10 Lewenstein Morphine derivative
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7056500B2 (en) * 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
DE60318041T2 (de) * 2002-05-16 2008-11-27 N.V. Organon Synergetische Kombination eines Opiatanalgetikums und eines NSAID's
CN1925875A (zh) 2003-12-16 2007-03-07 尼克塔治疗亚拉巴马公司 化学改性的小分子
US20070207200A1 (en) 2006-03-06 2007-09-06 Pozen Inc. Dosage forms for administering combinations of drugs
JP2009535409A (ja) * 2006-05-03 2009-10-01 コーワ ファーマシューティカルズ アメリカ,インコーポレイティド 即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬
JP2010509227A (ja) * 2006-11-07 2010-03-25 ネクター セラピューティックス エイエル,コーポレイション オピオイド作動薬およびオピオイド拮抗薬の用量形態および同時投与
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
CN101646464B (zh) * 2007-03-12 2013-05-29 尼克塔治疗公司 低聚物-阿片样激动剂偶联物
EP2022778A1 (en) * 2007-08-07 2009-02-11 Laboratorios del Dr. Esteve S.A. A crystalline form of (R,R)-tramadol-(S)-naproxene salt
MX347741B (es) 2008-09-16 2017-05-10 Nektar Therapeutics Opioides pegilados con bajo potencial de abuso.
EP2381937A2 (en) * 2008-12-31 2011-11-02 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
MX2012000980A (es) * 2009-07-21 2012-06-12 Nektar Therapeutics Conjugados de agonistas de oligómeros-opioides.
DK2459183T3 (en) * 2009-07-27 2016-01-18 Nocicepta Llc Methods for the treatment of pain
CA2785056A1 (en) 2009-12-22 2011-07-21 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
US20130023553A1 (en) 2010-01-12 2013-01-24 Nektar Therapeutics Pegylated opioids with low potential for abuse and side effects
WO2013070617A1 (en) 2011-11-07 2013-05-16 Nektar Therapeutics Compositions, dosage forms, and coadministration of an opioid agonist compound and an analgesic compound

Similar Documents

Publication Publication Date Title
RU2445312C2 (ru) ПРОИЗВОДНЫЕ 2-МЕТИЛМОРФОЛИН ПИРИДО-, ПИРАЗО- И ПИРИМИДО-ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ mTOR
JP2010265321A5 (enExample)
JP2012533546A5 (enExample)
JP2008195730A5 (enExample)
JP2011520977A5 (enExample)
JP2019521988A5 (enExample)
EA201490477A1 (ru) Фармацевтические составы, содержащие пропиленгликоль-гидрат дапаглифлозина
JP2009530398A5 (enExample)
JP2009534470A5 (enExample)
JP2013518107A5 (enExample)
JP2012502037A5 (enExample)
JP2012521429A5 (enExample)
JP2010540606A5 (enExample)
JP2011523645A5 (enExample)
JP2008543854A5 (enExample)
JP2013531029A5 (enExample)
JP2014515406A5 (enExample)
TW200833663A (en) Therapeutic agents
JP2013507423A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2015505296A5 (enExample)
JP2013542247A5 (enExample)
JP2009525302A5 (enExample)
JP2010523476A5 (enExample)
JP2013500304A5 (enExample)